Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.

Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains.

Rubin S, Mauldin J, Chumakov K, Vanderzanden J, Iskow R, Carbone K.

Vaccine. 2006 Mar 24;24(14):2662-8. Epub 2005 Nov 8.

PMID:
16309801
2.

Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003.

Atrasheuskaya AV, Blatun EM, Kulak MV, Atrasheuskaya A, Karpov IA, Rubin S, Ignatyev GM.

Vaccine. 2007 Jun 11;25(24):4651-8. Epub 2007 Apr 25.

PMID:
17498853
3.

Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004.

Atrasheuskaya AV, Kulak MV, Rubin S, Ignatyev GM.

Clin Microbiol Infect. 2007 Jul;13(7):670-6. Epub 2007 May 2.

4.

Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.

Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ, Rota PA, Sirota L, Beeler J.

J Infect Dis. 2008 Aug 15;198(4):508-15. doi: 10.1086/590115.

PMID:
18558869
5.

Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach.

Kulkarni-Kale U, Ojha J, Manjari GS, Deobagkar DD, Mallya AD, Dhere RM, Kapre SV.

Virology. 2007 Mar 15;359(2):436-46. Epub 2006 Nov 1.

6.
7.

Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype.

Nöjd J, Tecle T, Samuelsson A, Orvell C.

Vaccine. 2001 Feb 8;19(13-14):1727-31.

PMID:
11166897
8.

Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes.

Inou Y, Nakayama T, Yoshida N, Uejima H, Yuri K, Kamada M, Kumagai T, Sakiyama H, Miyata A, Ochiai H, Ihara T, Okafuji T, Okafuji T, Nagai T, Suzuki E, Shimomura K, Ito Y, Miyazaki C.

J Med Virol. 2004 May;73(1):97-104.

PMID:
15042655
9.

Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.

Šantak M, Lang-Balija M, Ivancic-Jelecki J, Košutić-Gulija T, Ljubin-Sternak S, Forcic D.

Epidemiol Infect. 2013 Jun;141(6):1298-309. doi: 10.1017/S0950268812001896. Epub 2012 Sep 7.

PMID:
22954346
10.

Nasal antibody response to mumps virus after vaccination and natural infection.

Tanaka K, Baba K, Okada S, Okuno Y, Yamanishi K, Ueda S, Takahashi M, Yamada A.

Vaccine. 1992;10(12):824-7.

PMID:
1455908
11.
12.
13.
14.

Blocking ELISA for detection of mumps virus antibodies in human sera.

Berbers GA, Marzec AH, Bastmeijer M, van Gageldonk PG, Plantinga AD.

J Virol Methods. 1993 May;42(2-3):155-68.

PMID:
8514838
15.

Epidemiological standardization of a test for susceptibility to mumps.

Shehab ZM, Brunell PA, Cobb E.

J Infect Dis. 1984 May;149(5):810-2.

PMID:
6373967
16.

Antigenic relationships between six genotypes of the small hydrophobic protein gene of mumps virus.

Orvell C, Tecle T, Johansson B, Saito H, Samuelson A.

J Gen Virol. 2002 Oct;83(Pt 10):2489-96.

PMID:
12237432
17.

Antibodies against mumps virus component proteins.

Matsubara K, Iwata S, Nakayama T.

J Infect Chemother. 2012 Aug;18(4):466-71. doi: 10.1007/s10156-011-0358-3. Epub 2012 Jan 5.

PMID:
22215227
18.

Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein.

Cusi MG, Fischer S, Sedlmeier R, Valassina M, Valensin PE, Donati M, Neubert WJ.

Virus Res. 2001 Apr;74(1-2):133-7.

PMID:
11226581
19.

Variability of hemagglutinin-neuraminidase and nucleocapsid protein of vaccine and wild-type mumps virus strains.

Ivancic-Jelecki J, Santak M, Forcic D.

Infect Genet Evol. 2008 Sep;8(5):603-13. doi: 10.1016/j.meegid.2008.04.007. Epub 2008 Apr 22.

PMID:
18508415
20.

Comparison of a neutralization enzyme immunoassay and an enzyme-linked immunosorbent assay for evaluation of immune status of children vaccinated for mumps.

Harmsen T, Jongerius MC, van der Zwan CW, Plantinga AD, Kraaijeveld CA, Berbers GA.

J Clin Microbiol. 1992 Aug;30(8):2139-44.

Supplemental Content

Support Center